MAPT is differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. The mutations in the gene have been associated with several neurodegenerative disorders such as Alzheimers disease, Picks disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimers disease, Picks disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
25 ug of the indicated Human whole cell extracts was loaded onto a 12% SDS-PAGE gel. 3 ug/mL of the antibody was used in this experiment. The peptide sequence is present in a 45 kDa isoform. The protein may be modified by acetylation, glycosylation, and phosphorylation.
Researcher: Max Holzer, Paul Flechsig Institut of Brain Research, University of Leipzig Application: Western blotting Species + Tissue/Cell type: Lane 1: 10ug E.Coli: expressed human Tau-C Lane 2: 10ug E.Coli: expressed human Tau-E Lane 3: 10ug E.Coli: expressed human Tau-F Lane 4: 10ug E.Coli: expressed human Tau-B Lane 5: 10ug E.Coli: expressed human Fetal-Tau Lane 6: 10ug E.Coli: expressed human Tau-D Primary antibody dilution: 1:1000 Secondary antibody: Donkey anti-rabbit-HRP Secondary antibody dilution: 1:10,000
MAPT antibody - middle region (ARP48103_P050) in Human HepG2 using Western Blot
* VAT and and shipping costs not included. Errors and price changes excepted